The Rockefeller University Clinical Scholars (KL2) Program 2006-2016

Area of Science:

• Translational Science
• Medical Education
• Clinical Research

Background:

• The Rockefeller Clinical Scholars (KL2) Program, established in 1976, evolved into a Master's degree program in 2006.
• It is part of the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program.

Purpose of the Study:

• To provide junior translational investigators with essential team science and leadership skills.
• To facilitate the development and execution of human subjects research protocols.
• To offer supplementary tutorials on critical translational skills.

Main Methods:

• Approximately 15 trainees are supported annually through CTSA KL2 awards and university funds.
• Trainees work under senior investigator mentors and expert educators.
• The program includes a Master's degree curriculum and focused skill-building tutorials.

Main Results:

• Since 2006, 40 scholars have graduated, with 72% pursuing academic careers.
• 39 out of 40 graduates continue in translational research, securing $23 million in NIH awards and over $26 million in other funding.
• Graduates have made significant scientific discoveries and contributed to improving human health.

Conclusions:

• The Rockefeller KL2 Program serves as a successful model for translational science training.
• The program effectively prepares junior investigators for impactful careers in research and health improvement.